{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:41:50Z","timestamp":1787010110468,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1097\/md.0000000000000678","type":"journal-article","created":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T16:18:14Z","timestamp":1430497094000},"page":"e678","source":"Crossref","is-referenced-by-count":6,"title":["Exploring Spatial Overlap of High-Uptake Regions Derived From Dual Tracer Positron Emission Tomography\u2013Computer Tomography Imaging Using 18F-Fluorodeoxyglucose and 18F-Fluorodeoxythymidine in Nonsmall Cell Lung Cancer Patients"],"prefix":"10.1097","volume":"94","author":[{"given":"Jing","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligang","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xindong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210309","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.radonc.2004.12.007","article-title":"Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project","volume":"75","author":"Bentzen","year":"2005","journal-title":"Radiother Oncol"},{"key":"R2-5-20210309","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ijrobp.2010.09.004","article-title":"Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group","volume":"82","author":"Machtay","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R3-5-20210309","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ijrobp.2004.04.013","article-title":"Improved local control with higher doses of radiation in large-volume stage III non-small cell lung cancer","volume":"60","author":"Rengan","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R4-5-20210309","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0360-3016(01)01823-5","article-title":"Dose, volume, and tumor control prediction in primary radiotherapy of non-small cell lung cancer","volume":"52","author":"Willner","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R5-5-20210309","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","article-title":"Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study","volume":"16","author":"Bradley","year":"2015","journal-title":"Lancet Oncol"},{"key":"R6-5-20210309","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.ijrobp.2011.12.032","article-title":"Are the results of RTOG 0617 mysterious?","volume":"82","author":"Cox","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R7-5-20210309","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0360-3016(00)00467-3","article-title":"Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality","volume":"47","author":"Ling","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R8-5-20210309","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.radonc.2006.03.003","article-title":"[18F]fluoro-deoxy-glucose positron emission tomography ([18F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer","volume":"79","author":"Vanderstraeten","year":"2006","journal-title":"Radiother Oncol"},{"key":"R9-5-20210309","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0969-8051(95)02005-5","article-title":"Development of labeled thymidine analogs for imaging tumor proliferation","volume":"23","author":"Shields","year":"1996","journal-title":"Nucl Med Biol"},{"key":"R10-5-20210309","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ijrobp.2007.06.039","article-title":"Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study","volume":"70","author":"Lee","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R11-5-20210309","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/jnci\/94.14.1080","article-title":"Coexpression of glucose transporter 1 and matrix metalloproteinase-2 in human cancers","volume":"94","author":"Ito","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"R12-5-20210309","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/hed.21137","article-title":"Inhibition of cell proliferation and glucose uptake in human laryngeal carcinoma cells by antisense oligonucleotides against glucose transporter-1","volume":"31","author":"Zhou","year":"2009","journal-title":"Head Neck"},{"key":"R13-5-20210309","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"R14-5-20210309","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1073\/pnas.0913668107","article-title":"E3 ubiquitin ligase APC\/C-Cdh1 accounts for the Warburg effect by linking glycolysis to cell proliferation","volume":"107","author":"Almeida","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"R15-5-20210309","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"R16-5-20210309","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1200\/JCO.2010.32.4939","article-title":"Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using [(18)F]fluorodeoxyglucose and [(18)F]fluorothymidine positron emission tomography","volume":"29","author":"Zander","year":"2011","journal-title":"J Clin Oncol"},{"key":"R17-5-20210309","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.radonc.2010.10.011","article-title":"Simultaneous positron emission tomography (PET) assessment of metabolism with (1)(8)F-fluoro-2-deoxy-d-glucose (FDG), proliferation with (1)(8)F-fluoro-thymidine (FLT), and hypoxia with (1)(8)fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study","volume":"98","author":"Vera","year":"2011","journal-title":"Radiother Oncol"},{"key":"R18-5-20210309","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.radonc.2011.08.048","article-title":"Dose painting by contours versus dose painting by numbers for stage II\/III lung cancer: Practical implications of using a broad or sharp brush","volume":"100","author":"Meijer","year":"2011","journal-title":"Radiother Oncol"},{"key":"R19-5-20210309","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijrobp.2014.01.047","article-title":"Correlation of (18)F-FDG avid volumes on pre-radiation therapy and post-radiation therapy FDG PET scans in recurrent lung cancer","volume":"89","author":"Shusharina","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R20-5-20210309","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2012.03.005","article-title":"The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer","volume":"104","author":"van Elmpt","year":"2012","journal-title":"Radiother Oncol"},{"key":"R21-5-20210309","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.canrad.2011.04.003","article-title":"State of the art on dose prescription, reporting and recording in intensity-modulated radiation therapy (ICRU report No. 83)","volume":"15","author":"Gr\u00e9goire","year":"2011","journal-title":"Cancer Radiother"},{"key":"R22-5-20210309","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.ijrobp.2007.11.042","article-title":"Comparison of different strategies to use four-dimensional computed tomography in treatment planning for lung cancer patients","volume":"70","author":"Wolthaus","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R23-5-20210309","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3109\/0284186X.2011.581694","article-title":"A planning study of radiotherapy dose escalation of PET-active tumour volumes in non-small cell lung cancer patients","volume":"50","author":"M\u00f8ller","year":"2011","journal-title":"Acta Oncol"},{"key":"R24-5-20210309","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1088\/0031-9155\/38\/6\/001","article-title":"A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density","volume":"38","author":"Webb","year":"1993","journal-title":"Phys Med Biol"},{"key":"R25-5-20210309","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/09553009214552071","article-title":"Tumour and normal tissue responses to fractionated non-uniform dose delivery","volume":"62","author":"K\u00e4llman","year":"1992","journal-title":"Int J Radiat Biol"},{"key":"R26-5-20210309","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1259\/bjr\/89275085","article-title":"Comparison of the helical tomotherapy against the multileaf collimator-based intensity-modulated radiotherapy and 3D conformal radiation modalities in lung cancer radiotherapy","volume":"84","author":"Mavroidis","year":"2011","journal-title":"Br J Radiol"},{"key":"R27-5-20210309","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ijrobp.2006.12.067","article-title":"PET-CT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes","volume":"68","author":"van Baardwijk","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R28-5-20210309","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.radonc.2009.03.006","article-title":"Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan","volume":"91","author":"Aerts","year":"2009","journal-title":"Radiother Oncol"},{"key":"R29-5-20210309","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.lungcan.2014.10.016","article-title":"Pre-treatment FDG-PET predicts the site of in-field progression following concurrent chemoradiotherapy for stage III non-small cell lung cancer","volume":"87","author":"Ohri","year":"2015","journal-title":"Lung Cancer"},{"key":"R30-5-20210309","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.radonc.2012.09.012","article-title":"Correlation of PET images of metabolism, proliferation and hypoxia to characterize tumor phenotype in patients with cancer of the oropharynx","volume":"105","author":"Nyflot","year":"2012","journal-title":"Radiother Oncol"},{"key":"R31-5-20210309","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.2967\/jnumed.111.098087","article-title":"Tumor microenvironment-dependent 18F-FDG, 18F-fluorothymidine, and 18F-misonidazole uptake: a pilot study in mouse models of human non-small cell lung cancer","volume":"53","author":"Huang","year":"2012","journal-title":"J Nucl Med"},{"key":"R32-5-20210309","doi-asserted-by":"crossref","first-page":"866","DOI":"10.2967\/jnumed.109.069310","article-title":"18F-FLT PET\/CT for early response monitoring and dose escalation in oropharyngeal tumors","volume":"51","author":"Troost","year":"2010","journal-title":"J Nucl Med"},{"key":"R33-5-20210309","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.radonc.2014.04.002","article-title":"Histopathologic validation of 3\u2019-deoxy-3\u2019-(18)F-fluorothymidine PET for detecting tumor repopulation during fractionated radiotherapy of human FaDu squamous cell carcinoma in nude mice(18)F-FLT PET repopulation","volume":"111","author":"Yue","year":"2014","journal-title":"Radiother Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000000678","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:42:31Z","timestamp":1620945751000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201505010-00005"}},"subtitle":["A Prospective Pilot Study"],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":33,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000000678","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}